US Broker Ratings

The Cigna Group (CI) Investor Outlook: Analysts Signal 23% Upside Potential

The Cigna Group (NYSE: CI), a formidable player in the healthcare plans industry, stands as a compelling investment opportunity with a market capitalization of $72.74 billion...

Insmed Incorporated (INSM) Stock Report: A Biotech Powerhouse with 66% Potential Upside

For investors with a keen interest in biotechnology, Insmed Incorporated (NASDAQ: INSM) presents a compelling opportunity. With a market cap of $26.21 billion, this U.S.-based healthcare..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 20% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, has captured the attention of investors with its impressive..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing the attention of investors with its promising 22.59% potential upside, according to the latest analyst ratings. As a key..

Qiagen N.V. (QGEN) Stock Report: A Healthcare Giant with a Potential Upside of 6.78%

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, continues to be a focal point for investors in the diagnostics and research industry. Headquartered in..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Healthcare Under the Spotlight with a 4.15% Upside

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is drawing investors’ attention with its unique positioning in the managed healthcare sector...

AstraZeneca PLC (AZN) Stock Analysis: Is a 27.75% Upside on the Horizon?

AstraZeneca PLC (NASDAQ: AZN), a leading biopharmaceutical company headquartered in Cambridge, UK, continues to capture investor attention with its robust pipeline of prescription medicines and strategic..

Bruker Corporation (BRKR) Stock Analysis: Assessing Growth Potential Amid a Rapidly Evolving Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $9.35 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring Growth Potential with a 13.71% Upside

Investors seeking opportunities in the medical instruments and supplies sector might find Stevanato Group S.p.A. (NYSE: STVN) an intriguing prospect. With a market capitalization of $5.92..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18.84% Potential Upside Beckons Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 31.56% Upside in the Precision Oncology Space

Revolution Medicines, Inc. (NASDAQ: RVMD) commands attention within the biotechnology sector, boasting a remarkable market capitalization of $40.93 billion. This clinical-stage precision oncology company, headquartered in..

Repligen Corporation (RGEN) Investor Outlook: Strong Buy Ratings and Growth Potential in Bioprocessing Technologies

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, as a dynamic player with significant growth potential...

BeOne Medicines Ltd. (ONC) Stock Analysis: A 23% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based oncology-focused biotechnology company, has caught the attention of investors with its promising pipeline of cancer treatments and a significant potential..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and 12.66% Potential Upside Drive Investor Interest

Genmab A/S (NASDAQ: GMAB), a powerhouse in the biotechnology sector, has piqued the interest of investors with its robust performance and potential for growth. Headquartered in..

Glaukos Corporation (GKOS) Stock Analysis: Investors Eye 20% Upside Potential Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector specializing in medical devices, has captured the attention of investors with its promising growth prospects..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with a 55% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands at the forefront of the biotechnology sector, with a market cap of $32.06 billion, making it a significant player in..

ICON plc (ICLR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 11.5% Potential Upside in the Biotech Royalty Space

Royalty Pharma plc (NASDAQ: RPRX) is a prominent player in the healthcare sector, particularly within the biotechnology industry, where it stands out as a unique entity...

McKesson Corporation (MCK)

⚠️ No article content returned.

..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 28.64% Potential Upside

In the ever-evolving landscape of the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player within the medical devices industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds